Interdisciplinary Strategies for Optimizing Prenatal Genetic Screening in Family-Centered Care Systems
Abstract
Background: Prenatal genetic screening has evolved from basic serum tests into a sophisticated component of modern reproductive care, capable of assessing risk for a wide range of fetal chromosomal and genetic conditions. This expansion, which now includes first and second-trimester serum analytics, nuchal translucency ultrasound, cell-free DNA (cfDNA) testing, and universal carrier screening, necessitates a highly coordinated and informed approach to ensure equitable and effective patient care.
Aim: This article aims to outline interdisciplinary strategies for optimizing prenatal genetic screening within a family-centered care model. It emphasizes the critical role of patient education, shared decision-making, and the careful integration of various screening modalities to support informed reproductive choices.
Methods: The review synthesizes established clinical procedures and guidelines, detailing the technical execution of screening methods, appropriate specimen collection, and the interpretation of complex results. It highlights the importance of pre-test and post-test genetic counseling to navigate the benefits, limitations, and potential outcomes of each testing pathway.
Results: A patient-centered approach, where all pregnant individuals are offered screening regardless of perceived risk, is fundamental. While cfDNA offers high sensitivity for common aneuploidies, factors like low fetal fraction can lead to indeterminate results. All positive screens require confirmation with diagnostic procedures like amniocentesis. Effective management relies on clear communication among clinicians, genetic counselors, sonographers, and laboratory staff.
Conclusion: Optimizing prenatal genetic screening requires a collaborative, interdisciplinary effort focused on patient safety, education, and ethical counseling. This integrated model empowers families with knowledge, facilitates early diagnosis and planning, and ultimately improves maternal-fetal outcomes.
Full text article
References
Cuckle H, Maymon R. Development of prenatal screening--A historical overview. Semin Perinatol. 2016 Feb;40(1):12-22.
Practice Bulletin No. 162: Prenatal Diagnostic Testing for Genetic Disorders. Obstet Gynecol. 2016 May;127(5):e108-e122.
American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Obstetrics; Committee on Genetics; Society for Maternal-Fetal Medicine. Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin, Number 226. Obstet Gynecol. 2020 Oct;136(4):e48-e69.
Committee Opinion No. 690: Carrier Screening in the Age of Genomic Medicine. Obstet Gynecol. 2017 Mar;129(3):e35-e40.
Committee Opinion No. 691: Carrier Screening for Genetic Conditions. Obstet Gynecol. 2017 Mar;129(3):e41-e55.
Abuhamad A. Technical aspects of nuchal translucency measurement. Semin Perinatol. 2005 Dec;29(6):376-9.
Hixson L, Goel S, Schuber P, Faltas V, Lee J, Narayakkadan A, Leung H, Osborne J. An Overview on Prenatal Screening for Chromosomal Aberrations. J Lab Autom. 2015 Oct;20(5):562-73.
Malone FD, Canick JA, Ball RH, Nyberg DA, Comstock CH, Bukowski R, Berkowitz RL, Gross SJ, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Dukes K, Bianchi DW, Rudnicka AR, Hackshaw AK, Lambert-Messerlian G, Wald NJ, D'Alton ME., First- and Second-Trimester Evaluation of Risk (FASTER) Research Consortium. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med. 2005 Nov 10;353(19):2001-11.
Carlson LM, Vora NL. Prenatal Diagnosis: Screening and Diagnostic Tools. Obstet Gynecol Clin North Am. 2017 Jun;44(2):245-256.
Fu XL, Hou W, Zhang ML, Xie XX, Meng Y, Zhou HH, Zhao QD, Hu JL, Mo GP, Lu YP. [Carrier screening and prenatal diagnosis analysis of high-risk cases in 3 044 preconception and early pregnancy couples]. Zhonghua Fu Chan Ke Za Zhi. 2025 Mar 25;60(3):161-170.
Gregg AR, Skotko BG, Benkendorf JL, Monaghan KG, Bajaj K, Best RG, Klugman S, Watson MS. Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics. Genet Med. 2016 Oct;18(10):1056-65.
Temming LA, Macones GA. What is prenatal screening and why to do it? Semin Perinatol. 2016 Feb;40(1):3-11.
Post AL, Mottola AT, Kuller JA. What's New in Prenatal Genetics? A Review of Current Recommendations and Guidelines. Obstet Gynecol Surv. 2017 Oct;72(10):610-617.
Lannoo L, Van Den Bogaert K, Belmans A, Brison N, Dehaspe L, De Langhe E, Vancoillie L, Parijs I, Vermeesch JR, Devriendt K, Van Calsteren K. Persistent Uninterpretable or Failed Prenatal Cell-Free DNA Screening Indicates a High-Risk Pregnancy and is Associated With Biological Factors Interfering With cfDNA-Analysis: A Prospective Cohort Study. Prenat Diagn. 2025 May;45(5):581-590.
Curnow KJ, Wilkins-Haug L, Ryan A, Kırkızlar E, Stosic M, Hall MP, Sigurjonsson S, Demko Z, Rabinowitz M, Gross SJ. Detection of triploid, molar, and vanishing twin pregnancies by a single-nucleotide polymorphism-based noninvasive prenatal test. Am J Obstet Gynecol. 2015 Jan;212(1):79.e1-9.
Varthaliti A, Fasoulakis Z, Lygizos V, Zolota V, Chatziioannou MI, Daskalaki MA, Daskalakis G, Antsaklis P. Safety of Obstetric Ultrasound: Mechanical and Thermal Indexes-A Systematic Review. J Clin Med. 2024 Nov 01;13(21)
Judah H, Gil MM, Syngelaki A, Galeva S, Jani J, Akolekar R, Nicolaides KH. Cell-free DNA testing of maternal blood in screening for trisomies in twin pregnancy: updated cohort study at 10-14 weeks and meta-analysis. Ultrasound Obstet Gynecol. 2021 Aug;58(2):178-189.
Committee Opinion No. 693: Counseling About Genetic Testing and Communication of Genetic Test Results. Obstet Gynecol. 2017 Apr;129(4):e96-e101.
Dukhovny S, Norton ME. What are the goals of prenatal genetic testing? Semin Perinatol. 2018 Aug;42(5):270-274.
Authors
Copyright (c) 2025 Ali Ahmad Altherwi, Hamoud Awad Al-Harbi, Matar Omishan Alhazmi, Fahad Lafi Aljohani , Yasser Ali Mubrk Alsuhimi, Abdullah Mastour M, Naif Gobishan ALsuhaymi , Ataallah Awadh Alsehaimi, Turke Ali Alajmi , Ahmad Abdulsattar Zaghoun, Marwan Saud Alharbi
This work is licensed under a Creative Commons Attribution 4.0 International License.